ATS 2018 International Conference - Mobile

Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells [Board No. 415]

Location: Board no. 415

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

22

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Graham Ogg

DPhil, FRCP
MRC Human Immunology Unit;University of Oxford

Wentao Chen

MSc
University of Oxford

Luzheng Xue

PhD
University of Oxford

Clare Hardman

Post-doc
MRC Human Immunology Unit;University of Oxford

Paul Batty

BA
University of Oxford

David Sandham

PhD
Novartis Institutes for Biomedical Research

Veit Johannes. Erpenbeck

MD, PhD
Novartis;Novartis Pharma AG

View Abstract

Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells

Parent Sessions

C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
05-22-2018 2:15 PM - 4:15 PM